MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Purchases 4,492 Shares of Option Care Health, Inc. $OPCH

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its stake in shares of Option Care Health, Inc. (NASDAQ:OPCH) by 4.6% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 102,178 shares of the company’s stock after purchasing an additional 4,492 shares during the quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. owned about 0.06% of Option Care Health worth $3,571,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors also recently added to or reduced their stakes in the stock. Public Employees Retirement System of Ohio increased its position in Option Care Health by 21.6% during the 4th quarter. Public Employees Retirement System of Ohio now owns 1,870 shares of the company’s stock valued at $43,000 after buying an additional 332 shares in the last quarter. US Bancorp DE lifted its holdings in shares of Option Care Health by 5.0% in the 1st quarter. US Bancorp DE now owns 8,199 shares of the company’s stock valued at $287,000 after buying an additional 393 shares during the period. State of Michigan Retirement System lifted its holdings in shares of Option Care Health by 1.2% in the 1st quarter. State of Michigan Retirement System now owns 40,759 shares of the company’s stock valued at $1,425,000 after buying an additional 500 shares during the period. Louisiana State Employees Retirement System grew its position in shares of Option Care Health by 1.1% during the 1st quarter. Louisiana State Employees Retirement System now owns 47,700 shares of the company’s stock valued at $1,667,000 after acquiring an additional 500 shares during the period. Finally, State of Alaska Department of Revenue grew its position in shares of Option Care Health by 2.7% during the 1st quarter. State of Alaska Department of Revenue now owns 19,931 shares of the company’s stock valued at $696,000 after acquiring an additional 525 shares during the period. Institutional investors own 98.05% of the company’s stock.

Option Care Health Trading Down 3.0%

NASDAQ:OPCH opened at $28.48 on Friday. The stock has a 50-day simple moving average of $29.09 and a 200-day simple moving average of $31.44. The stock has a market cap of $4.62 billion, a P/E ratio of 22.78, a P/E/G ratio of 1.79 and a beta of 0.82. Option Care Health, Inc. has a 1 year low of $21.39 and a 1 year high of $35.53. The company has a debt-to-equity ratio of 0.81, a quick ratio of 1.00 and a current ratio of 1.52.

Option Care Health (NASDAQ:OPCH) last posted its earnings results on Wednesday, July 30th. The company reported $0.41 EPS for the quarter, topping analysts’ consensus estimates of $0.40 by $0.01. The business had revenue of $1.42 billion for the quarter, compared to analysts’ expectations of $1.35 billion. Option Care Health had a return on equity of 17.53% and a net margin of 3.93%.The business’s revenue was up 15.4% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.30 earnings per share. Option Care Health has set its FY 2025 guidance at 1.650-1.720 EPS. As a group, analysts anticipate that Option Care Health, Inc. will post 1.22 earnings per share for the current fiscal year.

Insider Transactions at Option Care Health

In other Option Care Health news, Director Norman L. Wright bought 3,411 shares of the firm’s stock in a transaction dated Tuesday, September 9th. The stock was acquired at an average price of $29.31 per share, for a total transaction of $99,976.41. Following the completion of the purchase, the director owned 15,501 shares of the company’s stock, valued at approximately $454,334.31. This represents a 28.21% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Harry M. Jansen Kraemer, Jr. bought 36,000 shares of the firm’s stock in a transaction dated Wednesday, August 20th. The shares were acquired at an average price of $27.15 per share, with a total value of $977,400.00. Following the purchase, the director directly owned 375,390 shares of the company’s stock, valued at approximately $10,191,838.50. This trade represents a 10.61% increase in their position. The disclosure for this purchase can be found here. Over the last quarter, insiders acquired 59,411 shares of company stock worth $1,627,576. Company insiders own 0.64% of the company’s stock.

Analyst Ratings Changes

A number of brokerages recently weighed in on OPCH. Citigroup reaffirmed an “outperform” rating on shares of Option Care Health in a research note on Thursday, July 31st. JMP Securities boosted their price target on shares of Option Care Health from $36.00 to $38.00 and gave the stock a “market outperform” rating in a research report on Thursday, July 31st. Finally, Barrington Research reissued an “outperform” rating and issued a $38.00 price target on shares of Option Care Health in a research note on Thursday, July 10th. Eight equities research analysts have rated the stock with a Buy rating and one has given a Hold rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $35.75.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.